Figure 2 | Scientific Reports

Figure 2

From: Reduced economic disparity in biologics use for psoriasis after introducing the reducing copayment program

Figure 2

Drug survival of biologics for treating moderate-to-severe psoriasis according to income levels (a) before the introduction of the RCP (June 2017) and (b) after the introduction of the RCP. All groups, except MA, were classified according to income levels among NHIS beneficiaries. RCP reducing copayment program, MA medical aid, NHIS National Health Insurance Service, No number.

Back to article page